Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPN171H tablets in mild-to-moderate erectile dysfunction
CTR20221151Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TPN171H in erectile dysfunction (ED), sponsored by Shanghai Institute of Materia Medica. Started May 2022; status: completed.
02
Drugs
TPN171H
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on CTR20221151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221151.